[The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis].
D000328:Adult; D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000097:blood / Q000150:complications*; D004591:Electrophoresis, Polyacrylamide Gel; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood* / Q000150:complications; D006949:Hyperlipidemias / Q000097:blood* / Q000150:complications; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008053:Lipid Mobilization; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000150:complications; D010743:Phospholipids / Q000097:blood; D012855:Sitosterols / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D000960:Hypolipidemic Agents; D008074:Lipoproteins; D010743:Phospholipids; D012855:Sitosterols; D014280:Triglycerides; D002792:Cholestyramine Resin; D002784:Cholesterol; D002994:Clofibrate
Znachenie opredeleniia tipa giperlipidemii dlia lipotropnoi terapii ateroskleroza.